로딩 중…
지수 로딩 중…
Ardelyx, Inc.
ARDX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$6.05+3.60%
2026-06-18
Price Chart
Ardelyx, Inc.+67.59%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.49B |
| Revenue | $428M |
| Net Income | $-58M |
| Total Assets | $505M |
| Net Assets | $149M |
| Value | |
| P/B | 10.06x |
| P/S | 3.49x |
| FCF Yield | -2.51% |
| Profitability | |
| ROE | -39.07% |
| ROA | -11.51% |
| Op. Margin | -8.75% |
| Revenue Growth | 27.47% |
| Financial Health | |
| Debt Ratio | 239.46% |
| Total Debt | $208M |
| FCF | $-37M |
| Cash | $31M |
| Current Ratio | 3.49x |
| Performance | |
| 1Y Return | 67.59% |
| 1M Return | -0.66% |
| From 52W High | -27.98% |
| 1Y MDD | -34.12% |
| Trading | |
| Volume | 7,722,955 shares |
| Trading Value | $46M |
| Per Share | |
| EPS | $-0.25 |
| BPS | $0.69 |